Skip to main content
. 2021 Jan 1;11(2):941–957. doi: 10.7150/thno.44948

Table 1.

'Cancer-to-normal' ratio of EDB-FN expression in carcinomas of various organs

Organ Number of cancer samples Number of normal samples 'cancer-to-normal' ratio (mean ± std. dev., A.U.) Cancer vs normal,p value
Brain 2517 723 1.420 ± 0.229 < 0.0001
Head and Neck 360 119 1.561 ± 0.358 < 0.0001
Oral 309 167 1.296 ± 0.323 < 0.0001
Thyroid 338 197 1.374 ± 0.305 < 0.0001
Lung 2502 650 1.195 ± 0.279 < 0.0001
Breast 5516 471 1.284 ± 0.253 < 0.0001
Gastric 934 110 1.168 ± 0.152 < 0.0001
Liver 524 322 1.077 ± 0.206 < 0.0001
Pancreatic 240 98 1.325 ± 0.465 < 0.0001
Colon 2449 500 1.109 ± 0.217 < 0.0001
Adrenal 355 50 0.996 ± 0.171 nonsignificant
Renal 504 195 1.181 ± 0.196 < 0.0001
Ureter 58 45 0.919 ± 1.058 nonsignificant
Ovarian 1146 92 1.265 ± 0.324 < 0.0001
Uterine 387 192 1.103 ± 0.329 < 0.05
Prostate 257 75 1.419 ± 0.528 < 0.0001
Skin 454 488 1.042 ± 0.173 < 0.0001

Statistical analysis: Mann-Whitney test. A.U: arbitrary unit; std. dev: standard deviation.